Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells

Regulatory Peptides

Volumn 120, Issue 1-3, 2004, Pages 155-166

  Hassan, Sazzad ^a   Dobner, Paul R ^a   Carraway, Robert E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

EGFR; ERK; Neurotensin; PC3; PI3 kinase

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; AMPHIREGULIN; ANDROGEN; BISINDOLYLMALEIMIDE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHORAMIDON; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE INHIBITOR; ROTTLERIN; STAUROSPORINE; STRESS ACTIVATED PROTEIN KINASE; WORTMANNIN;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; MITOGENESIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; DNA, NEOPLASM; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; LIGANDS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROTENSIN; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTOR, EPIDERMAL GROWTH FACTOR; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 2642535866     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.03.004     Document Type: Article

References (66)

1. Boring C.C., Squires T.S., Tong T. Cancer statistics. CA Cancer J. Clin. 43(1):1993;7-26
2. Carter H.B., Isaacs J.T. Overview of hormonal therapy for prostate cancer. Prog. Clin. Biol. Res. 350:1990;129-140
3. Jones H.E., Eaton C.L., Barrow D., Dutkowski C.M., Gee J.M., Griffiths K. Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines. Prostate. 30:1997;219-231
4. Eaton C.L., Davies P., Phillips M.E. Growth factor involvement and oncogene expression in prostatic tumours. J. Steroid Biochem. 30(1-6):1988;341-345
5. Gioeli D., Mandell J.W., Petroni G.R., Frierson H.F. Jr., Weber M.J. Activation of mitogen activated protein kinase associated with prostate cancer progression. Cancer Res. 59:1999;279-284
6. Price D.T., Della Rocca G.J., Guo C., Ballo M.S., Schwinn D.A., Luttrell L.M. Activation of extracellular signal-regulated kinase in human prostate cancer. J. Urol. 162:1999;1537-1542
7. Kue P.F., Taub J.S., Barki-Harrington L., Polakiewicz R.D., Ullrich A., Daaka Y. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC3 cells. Int. J. Cancer. 2002;572-579
8. Massague J., Pandiella A. Membrane-anchored growth factors. Annu. Rev. Biochem. 62:1993;515-541
9. Adam R.M., Kim J., Lin J., Orsola A., Zhuang L., Rice D.C., et al. Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function. Endocrinology. 143(12):2002;4599-4608
10. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:1999;143-180
11. Murphy L.O., Smith S., Chen R.H., Fingar D.C., Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4(8):2002;556-564
12. Brunet A., Roux D., Lenormand P., Dowd S., Keyse S., Pouyssegur J. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18(3):1999;664-674
13. Falkmer S., Askensten L., Grimelius L., Abrahamsson P.A. Cytochemical markers and DNA content of neuroendocrine cells in carcinoma of the prostate gland during tumour progression. Acta Histochem. 38:1990;127-132. [Suppl]
14. Barki-Harrington L., Daaka Y. Bradykinin induced mitogenesis of androgen independent prostate cancer cells. J. Urol. 165:2001;2121-2125
15. Segal I., Powers S., Huntley B., Powis G., Pittelkow M., Maihle N.J. Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc. Natl. Acad. Sci., U. S. A. 91:1994;4673-4677
16. Seethalakshmi L., Mitra S.P., Dobner P.R., Menon M., Caraaway R.E. Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate. 31:1997;183-192
17. Carraway R.E., Leeman S.E. Characterization of radioimmunoassayable neurotensin in the rat: its differential distribution in the central nervous system, small intestine and stomach. J. Biol. Chem. 251:1976;7045-7052
18. Reinecke M. Neurotensin: immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone. Prog. Histochem. Cytochem. 16:1985;1-175
19. Wood J.G., Hoang H.D., Bussjaeger L.J., Solomon T.E. Neurotensin stimulates growth of the small intestine in rats. Am. J. Physiol. 255:1988;813-817
20. Tatsuta M., Iishi H., Baba M., Taniguchi H. Promotion by neurotensin of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res. 49:1989;843-846
21. Ishizuka J., Townsend C.M., Thompson J.C. Neurotensin regulates growth of human pancreatic cancer. Ann. Surg. 217:1993;439-446
22. Maoret J.J., Anini Y., Rouyer-Fessard C., Gully D., Laburthe M. Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cell xenografted into nude mice. Int. J. Cancer. 80:1999;448-454
23. Davis T.P., Burgess H.S., Crowell S., Moody T.W., Gulling-Berglund A., Liu R.H. β-Endorphin and neurotensin stimulate in vitro clonal growth of human SCLC cells. Eur. J. Pharmacol. 161:1989;283-285
24. Rosell S., Rokaeus A. The effects of ingestion of amino acids, glucose and fat on circulating neurotensin-like immunoreactivity (NTLI) in man. Acta Physiol. Scand. 107:1979;263-267
25. Ferris C.F. Neurotensin. Handbook of Physiology. The Gastrointestinal System. Bethesda, MD. Am. Physiol. Soc. vol. 6:1989;559-586
26. Giovanucci E.J., Rimm E.B., Colditz G.A. A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst. 85:1993;1571-1579
27. Elek J., Pinzon W., Park K.H., Narayanan R. Relevant genomics of neurotensin receptor in cancer. Anticancer Res. 20:2000;53-58
28. Vincent J.P., Mazella J., Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol. Sci. 20(7):1999;302-309
29. Hasagawa K., Siddhartha K., Carr B.I. Stimulation of hepatocyte DNA synthesis by neurotensin. J. Cell. Physiol. 158:1994;215-222
30. Pierce K.L., Luttrell L.M., Lefkowitz R.J. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene. 20:2001;1532-1539
31. Marinissen M.J., Gutkind J.S. G protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol. Sci. 22:2001;368-376
32. Della Rocca G.J., vam Biesen T., Daaka Y., Luttrell D.K., Luttrell L.M., Lefkowitz R.J. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. J. Biol. Chem. 272:1997;19125-19132
33. Luttrell L.M., Daaka Y., Lefkowitz R.J. Regulation of tyrosine kinase cascades by G protein-coupled receptors. Curr. Opin. Cell Biol. 11:1999;177-183
34. Gschwind A., Hart S., Fischer O.M., Ullrich A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J. 22:2003;2411-2421
35. Daub H., Weiss F.U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signaling by G protein-coupled receptors. Nature. 379:1996;557-560
36. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402(6764):1999;884-888
37. Andresen B.T., Linnoila J.J., Jackson E.K., Romero G.G. Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells. Hypertension. 41:2003;781-786
38. Wang H., Ubl J.J., Stricker R., Reiser G. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am. J. Physiol. Cell Physiol. 283(5):2002;C1351-C1364
39. Seta K., Sadoshima J. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced transactivation of the epidermal growth factor receptor. J. Biol. Chem. 278:2000;9019-9026
40. Tice D.A., Biscardi J.S., Nickles A.L., Parsons S.J. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Natl. Acad. Sci., U. S. A. 96:1999;1415-1420
41. Dikic I., Tokiwa G., Lev S., Courtneidge S.A., Schlessinger J. A role for Pyk2 and Src in linking G protein-coupled receptors with MAP kinase activation. Nature. 383:1997;547-549
42. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., et al. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature. 364(6434):1993;249-252
43. Rizzo M.A., Shome K., Watkins S.C., Romero G. The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras. J. Biol. Chem. 275:2000;23911-23918
44. Newton A.C. Regulation of protein kinase C. Curr. Opin. Cell Biol. 9:1997;161-167
45. Ehlers R.A., Zhang Y., Hellmich M.R., Evers B.M. Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2. Biochem. Biophys. Res. Commun. 269(3):2000;704-708
46. Mitra S.P., Carraway R.E. Synergistic effects of neurotensin and beta-adrenergic agonist on 3, 5-cyclic adenosine monophosphate accumulation and DNA synthesis in prostate cancer PC3 cells. Biochem. Pharmacol. 57(12):1999;1391-1397
47. 2+-channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells. J. Pharmacol. Exp. Ther. 307:2003;640-650
48. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer. 2(7):2002;489-501
49. Roche S., Koegl M., Courtneidge S.A. The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl. Acad. Sci. U. S. A. 91(19):1994 (Sep 13);9185-9189
50. Higashiyama S., Abraham J.A., Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell. Biol. 122:1993;933-940
51. Singhal R.I., Prajda N., Yeh Y.A., Weber G. 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): A proliferation- and malignancy-linked signal transduction enzyme. Cancer Res. 54:1994;5574-5578
52. Grewal J.S., Luttrell L.M., Raymond J.R. G protein-coupled receptors desensitize and down-regulate epidermal growth factor receptors in renal mesangial cells. J. Biol. Chem. 276(29):2001;27335-27344
53. Goishi K., Higashiyama S., Klagsbrun M., Nakano N., Umata T., Ishikawa M., et al. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell. 6(8):1995;967-980
54. Iwamoto R., Handa Km., Mekada E. Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J. Biol. Chem. 274(36):1999;25906-25912
55. Eguchi S., Numaguchi K., Iwasaki H., Matsumoto T., Yamakawa T., Utsunomiya H., et al. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 273:1998;8890-8896
56. Eguchi S., Iwasaki H., Inagami T., Numaguchi K., Yamakawa T., Motley E.D., et al. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension. 33:1999;201-206
57. Shah B.H., Catt K.J. Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: roles of protein kinase Cδ, Src/proline-rich tyrosine kinase 2 and epidermal growth factor receptor treas-activation. Mol. Pharmacol. 61:2001;343-351
58. Ushio-Fukai M., Griendling K.K., Becker P.L., Hilenski L., Halleran S., Alexander R.W. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21(4):2001;489-495
59. Dethlefsen S.M., Raab G., Moses M.A., Adam R.M., Klagsbrun M., Freeman M.R. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. J. Cell. Biochem. 69:1998;143-153
60. Uchiyama-Tanaka Y., Matsubara H., Nozawa Y., Murasawa S., Mori Y., Kosaki A., et al. Angiotensin II signaling and HB-EGF sheding via metalloproteinase in glomerular mesangial cells. Kidney Int. 60:2001;2153-2163
61. Maudsley S., Pierce K.L., Zamah M., Miller W.E., Ahn S., Daaka Y., et al. The β2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J. Biol. Chem. 275:2000;9572-9580
62. Torring N., Jorgensen P.E., Sorensen B.S., Nexo E. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGFα and epiregulin in androgen-independent prostate cancer cell lines. Anticancer Res. 20:2000;91-96
63. Hermans E., Maloteaux J.M. Mechanisms of regulation of neurotensin receptors. Pharmacol. Ther. 79:1998;89-104
64. Bozou J.C., Rochet N., Magnaldo I., Kitabgi P., Vincent J.P. Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Biochem. J. 264:1989;871-878
65. Skryma R., Mariot P., Bourhis X.L., Coppenolle F.V., Shuba Y., Vander Abeele F., et al. Store depletion and stor-operated Ca2+ current in human prostate cancer LNCaP cells: involvement in apoptosis. J. Physiol. 527:2000;71-83
66. Corbit K.C., Trakul N., Eves E.M., Diaz B., Marshall M., Rosner M.R. Acativation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J. Biol. Chem. 278:2003;13061-13068